RVTY
Price
$120.62
Change
-$0.02 (-0.02%)
Updated
Nov 12, 03:35 PM (EDT)
78 days until earnings call
XRAY
Price
$17.52
Change
-$0.13 (-0.74%)
Updated
Nov 12, 03:41 PM (EDT)
106 days until earnings call
Ad is loading...

RVTY vs XRAY

Header iconRVTY vs XRAY Comparison
Open Charts RVTY vs XRAYBanner chart's image
Revvity
Price$120.62
Change-$0.02 (-0.02%)
Volume$200
CapitalizationN/A
DENTSPLY SIRONA
Price$17.52
Change-$0.13 (-0.74%)
Volume$1.4K
CapitalizationN/A
RVTY vs XRAY Comparison Chart
Loading...
RVTY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
RVTY vs. XRAY commentary
Nov 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVTY is a StrongBuy and XRAY is a Buy.

COMPARISON
Comparison
Nov 12, 2024
Stock price -- (RVTY: $120.64 vs. XRAY: $17.65)
Brand notoriety: RVTY and XRAY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RVTY: 159% vs. XRAY: 171%
Market capitalization -- RVTY: $12.76B vs. XRAY: $6.69B
RVTY [@Medical Specialties] is valued at $12.76B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVTY’s FA Score shows that 1 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • RVTY’s FA Score: 1 green, 4 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, both RVTY and XRAY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVTY’s TA Score shows that 4 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • RVTY’s TA Score: 4 bullish, 5 bearish.
  • XRAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than RVTY.

Price Growth

RVTY (@Medical Specialties) experienced а -3.35% price change this week, while XRAY (@Medical Specialties) price change was -24.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.52%. For the same industry, the average monthly price growth was +3.42%, and the average quarterly price growth was -2.29%.

Reported Earning Dates

RVTY is expected to report earnings on Jan 29, 2025.

XRAY is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Medical Specialties (+2.52% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than XRAY($6.69B). RVTY has higher P/E ratio than XRAY: RVTY (71.72) vs XRAY (19.23). RVTY YTD gains are higher at: 10.651 vs. XRAY (-49.540). RVTY has higher annual earnings (EBITDA): 714M vs. XRAY (249M). RVTY has more cash in the bank: 1.6B vs. XRAY (334M). XRAY has less debt than RVTY: XRAY (2.3B) vs RVTY (4.07B). XRAY has higher revenues than RVTY: XRAY (3.97B) vs RVTY (2.75B).
RVTYXRAYRVTY / XRAY
Capitalization12.8B6.69B191%
EBITDA714M249M287%
Gain YTD10.651-49.540-21%
P/E Ratio71.7219.23373%
Revenue2.75B3.97B69%
Total Cash1.6B334M480%
Total Debt4.07B2.3B177%
FUNDAMENTALS RATINGS
RVTY vs XRAY: Fundamental Ratings
RVTY
XRAY
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
8690
PRICE GROWTH RATING
1..100
3165
P/E GROWTH RATING
1..100
5190
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (4) in the Medical Specialties industry is significantly better than the same rating for RVTY (77). This means that XRAY’s stock grew significantly faster than RVTY’s over the last 12 months.

RVTY's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for XRAY (100). This means that RVTY’s stock grew somewhat faster than XRAY’s over the last 12 months.

RVTY's SMR Rating (86) in the Medical Specialties industry is in the same range as XRAY (90). This means that RVTY’s stock grew similarly to XRAY’s over the last 12 months.

RVTY's Price Growth Rating (31) in the Medical Specialties industry is somewhat better than the same rating for XRAY (65). This means that RVTY’s stock grew somewhat faster than XRAY’s over the last 12 months.

RVTY's P/E Growth Rating (51) in the Medical Specialties industry is somewhat better than the same rating for XRAY (90). This means that RVTY’s stock grew somewhat faster than XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RVTYXRAY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
69%
Bullish Trend 7 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 21 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
47%
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Ad is loading...
RVTY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XRAY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQQS29.360.36
+1.24%
Invesco NASDAQ Future Gen 200 ETF
TUR34.850.33
+0.96%
iShares MSCI Turkey ETF
TRND33.99N/A
N/A
Pacer Trendpilot Fund of Funds ETF
ILTB50.75-0.13
-0.26%
iShares Core 10+ Year USD Bond ETF
PDBC13.38-0.22
-1.62%
Invesco Optm Yd Dvrs Cdty Stra No K1 ETF

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been loosely correlated with TMO. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RVTY jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
-1.49%
TMO - RVTY
61%
Loosely correlated
-0.87%
SYK - RVTY
60%
Loosely correlated
+0.77%
A - RVTY
59%
Loosely correlated
-2.06%
MTD - RVTY
55%
Loosely correlated
-4.58%
WAT - RVTY
55%
Loosely correlated
-0.98%
More

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with KIDS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-1.18%
KIDS - XRAY
48%
Loosely correlated
-2.74%
HBIO - XRAY
46%
Loosely correlated
-4.67%
NVST - XRAY
44%
Loosely correlated
+1.77%
STE - XRAY
44%
Loosely correlated
+1.22%
ZBH - XRAY
43%
Loosely correlated
+1.18%
More